Navigation Links
TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications
Date:5/29/2012

the water quality, control of bacterial contaminations (sources of DNase RNase and Protease) and a few other parameters are the key to make high quality SDS. Two years ago, we decided to scale up this product and offer it to our customers worldwide. After extensive testing by our R&D team in preparations of Tris-glycine SDS-Buffers, we are assured that dust-free SDS not only provides increased safety in the laboratory, but actually leads to more consistent electrophoresis results. We are really excited that we were able innovate and enhance the safety of this widely used product."

After production of dust-free SDS, each batch is stringently tested to ensure it meets our physical specifications with regard to purity, density, solubility, and appearance, and then packed for shipment to end-users. For specific technical data and southern/western blot data, please visit: http://www.toku-e.com/product/Sodium_Dodecyl_Sulfate_(SDS)/.

About TOKU-E

TOKU-E specializes in the manufacturing of ultra-pure antimicrobials and fine chemicals for use in life science research. The broad range of antimicrobials produced are primarily designed for gene selection, cell culture, microbiology, anti-mycoplasma and diagnostic applications. In order to better serve their European customers, TOKU-E Company established last year a European establishment in Rotterdam, the Netherlands.


'/>"/>
SOURCE TOKU-E BV
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sequenom Announces Participation at the Jefferies Global Healthcare Conference
2. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
3. EPSRC announces first recipients of Fellowships in Manufacturing
4. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
5. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
6. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis
7. Diversionary Therapy Announces First Sale of ditto™ dental
8. IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
9. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
10. Cord Blood America Announces First Quarter Financial Results
11. Sigma-Aldrich Corporation Announces New Credit Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... BARBARA, CALIFORNIA (PRWEB) March 04, 2015 ... consulting firm in the life sciences industry, hired ... Blewitt leads the Cloud Compliance Services and Solutions ... companies utilize cloud based applications while maintaining compliance with ... years, Blewitt has been an accomplished life sciences regulatory ...
(Date:3/4/2015)... PRC Clinical, a full-service, ... Bay Area, will exhibit and present at the ... on March 25th and 26th in Tel Aviv, Israel. ... Israeli life science companies seeking to conduct U.S. Food ... span all phases of human trials, from Phase I ...
(Date:3/4/2015)... 2015 Vegalab announced the acquisition of Ecowin, ... year. As part of the acquisition, Ecowin rebranded itself ... his role as CEO for the company,s Korea operations. ... work alongside Koo and oversee developments at the new ... Koo founded Ecowin in 2008 to ...
(Date:3/4/2015)... , March 4, 2015 ... Entwicklungen für Diagnostik und Therapie, Strahlendosismanagement und IT-Lösungen ... Royal Philips (NYSE: PHG, AEX: ... Röntgenkongress 2015 (ECR) bekannt, der vom 4. bis ... An den Ständen Nr. 102 and 110 ...
Breaking Biology Technology:USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6
... PRINCETON, N.J., Oct. 26 Pharmasset, Inc.,(Nasdaq: VRUS ) management ... -- Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference ... the New York Palace Hotel in New York ... Officer, will provide an overview of the company ...
... Bionovo, Inc.,(Nasdaq: BNVI ) (the "Company") today announced that ... stock at a price to the public of,$2.50 per share ... per share at a price of $0.10 per warrant. The ... up to an additional 15% of,the offering to cover over-allotments. ...
... Call for Patient Group Task Force to Fight ... the views of bodies that,represent more than 121,000 ... - one of the world,s biggest net exporters ... for patient,groups across Europe to unite to battle ...
Cached Biology Technology:Pharmasset to Present at Three Investor Conferences in November 2007 2Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 2Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 3Patients Fail to Take Fake Medicines Risk Seriously 2Patients Fail to Take Fake Medicines Risk Seriously 3
(Date:2/24/2015)... 24, 2015 Research and Markets ... the "Global 2D Gesture Recognition Market 2015-2019" ... The analysts forecast the Global 2D Gesture Recognition ... over the period 2014-2019 The increased ... is one of the major trends in the ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... Bioinformatics Institute at Virginia Tech have assembled the draft ... across the US in a project that aims to ... The results have been published in Nature Communications. ... fuel sources to prevent a potential energy crisis and ...
... BIOLOGY -- When neutrons and simulation unite . . ... workhorses of the cellular world, could become easier by ... in Biophysical Journal. A team led by Oak Ridge ... high-performance computer simulation and a type of neutron analysis ...
... EAST LANSING, Mich. For children with autism, being ... to increase the severity of their symptoms, according to ... autistic children who were born either preterm or post-term ... children born on time, revealed the study by Tammy ...
Cached Biology News:April 2012 story tips 2April 2012 story tips 3April 2012 story tips 4Autistic kids born preterm, post-term have more severe symptoms 2
Mouse monoclonal antibody raised against a full length recombinant ATF3. NCBI Entrez Gene ID = ATF3...
... Delivers 4,600 to Over 3 Million Genotypes ... is capable of performing 4,600 to over ... the GenomeLab family of products*, this automated, ... 48 SNPs in each well of an ...
Mouse monoclonal antibody to ACP2 - acid phosphatase 2, lysosomal...
Mouse monoclonal antibody to DCAMKL2 - doublecortin and CaM kinase-like 2...
Biology Products: